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Background
A points-based scoring system defines levels of familial
risk for colorectal neoplasia. More than 7 points defines
a high-risk group that should undergo colonoscopy
every 3 years. Family History Scoring was applied to
families fulfilling Amsterdam I criteria and familial col-
orectal cancer type X to compare colon cancer risk.
Methods
Amsterdam I (AmI) and familial type X (famX) families
identified from Jagelman Registry database were scored.
Affected probands (AP), unaffected probands (UP),
affected sibling (AS), and unaffected sibling (US) of the
proband, and a child of each sibling were scored. Med-
ian, range, and standard deviation were compared for
each syndrome to determine level of risk.
Results
200 patients were included. 181 matched AmI criteria with
genetic testing, 19 matched criteria for famX. 37 families with
an AP and 12 with an UP matched AmI criteria. 4 with an
AP and 3 with an UP that matched criteria for famX. Level of
risk for the two syndromes were compared (Table 1). Median
family history score was 12 points for individuals fulfilling
AmI criteria and 14 for famX. Total mean was 12.8 for AmI
and 13.5 for famX. Median was compared between the two
syndromes (Figure 1), to assess level of risk.
Conclusions
Family history scoring system has shown that families ful-
filling Amsterdam I criteria and familial type X share simi-
lar familial risk level for developing colon cancer. Both
show dominant inheritance, but molecular pathways differ.
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Table 1 Comparing level of risk for AmI and famX (X) syndrome using Family History Scoring
AP AP/AS AP/US AP/AS Child AP/US Child UP UP/AS UP/US UP/AS Child UP/US Child Total Median
Median AmI 17 18 17 12 5 12 16 12 9 4 12
X 14 17 14 14 4 12 15 12 N/A N/A 14
Mean AmI 18.0 21.0 17.3 13.1 5.2 12.4 15.2 12.5 9.0 4.4 12.8
X 13.5 17.0 13.5 14.0 4.0 11.3 15.0 11.3 N/A N/A 13.5
Range AmI 9-42 14-44 9-30 9-21 4-13 6-19 10-19 6-21 6-12 2-12
X 11-15 17 11-15 14 4 7-15 15 7-15 N/A N/A
STDEV AmI 6.3 7.0 4.7 3.4 2.0 4.4 3.5 4.7 2.9 3.4 4.0
X 1.9 N/A 1.9 N/A 0.0 4.0 N/A 4.0 N/A N/A 1.9
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Figure 1 Comparing median score of AmI and famX syndrome using Family History Scoring.
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